Ozempic Debuts in India at Rs 2,200/Week; Novo Nordisk Warns on Misuse

• Ozempic, a diabetes and weight-loss drug, has launched in India at Rs 2,200 per weekly dose.
• Novo Nordisk implemented an "India-tiered pricing" strategy to ensure affordability for the drug.
• Distribution is underway, and Ozempic will soon be available in pharmacies across India in 0.25 mg, 0.5 mg, and 1 mg strengths.
• The company strongly cautions against unsupervised use of Ozempic, particularly for cosmetic weight loss, emphasizing medical supervision.
• India faces a significant health burden with 100 million diabetics and 250 million obese individuals.

Why It Matters: Affordable Ozempic launches in India, impacting diabetes/obesity but warns against misuse.